← Back to Analyst Consensus 
CGEM Buy
Cullinan Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 5, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Oct 2, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 25, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Sep 25, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Sep 14, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Aug 17, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 13, 2026 | Wedbush | maintain | Outperform → Outperform | — | 57% |
| Jul 29, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jun 11, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 57% |
| Jun 8, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 19, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| May 8, 2026 | Wedbush | maintain | Outperform → Outperform | — | 57% |
| May 4, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Apr 28, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Apr 28, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Mar 11, 2026 | Wedbush | maintain | Outperform → Outperform | — | 57% |
| Feb 17, 2026 | Citigroup | initiate | — → Buy | $33 | 54% |
| Feb 2, 2026 | Guggenheim | initiate | — → Buy | $30 | 52% |
| Jan 8, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $27 | 44% |
| Dec 9, 2025 | Wedbush | maintain | Outperform → Outperform | $34 | 57% |
| Nov 20, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $26 | 44% |
| Sep 12, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $24 | 44% |
| Sep 10, 2025 | BTIG | reiterate | Buy → Buy | $32 | 52% |
| Aug 18, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $28 | 54% |
| May 12, 2025 | UBS | maintain | Buy → Buy | $24 | 54% |
| Apr 16, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $33 | 44% |
| Feb 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $33 | 44% |
| Feb 28, 2025 | Stifel | maintain | Buy → Buy | $19 | 53% |
| Oct 24, 2024 | UBS | initiate | — → Buy | $30 | 54% |
| Aug 9, 2024 | Wedbush | reiterate | Outperform → Outperform | $36 | 57% |
| Jun 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $28 | 44% |
| May 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $28 | 44% |
| May 16, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $28 | 44% |
| May 16, 2024 | Wedbush | reiterate | Outperform → Outperform | $36 | 57% |
| May 1, 2024 | Stifel | initiate | — → Buy | $40 | 53% |
| Apr 17, 2024 | BTIG | maintain | Buy → Buy | $30 | 52% |
| Apr 17, 2024 | JonesTrading | maintain | Buy → Buy | $26 | 75% |
| Apr 16, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $29 | 44% |
| Apr 15, 2024 | William Blair | initiate | — → Outperform | $0 | 48% |
| Mar 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $34 | 44% |
| Feb 15, 2024 | Wedbush | initiate | — → Outperform | $30 | 57% |
| Oct 6, 2023 | JonesTrading | initiate | — → Buy | $22 | 75% |
| Aug 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $34 | 44% |
| Aug 9, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $49 | 44% |
| Jul 7, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $49 | 44% |
| Jun 15, 2023 | TD Cowen | initiate | — → Outperform | $0 | 54% |
| Jun 5, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $49 | 44% |
| May 26, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $49 | 44% |
| May 12, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $49 | 44% |
| Mar 27, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $50 | 44% |
Price Target Trend
Apr 27, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days